Tumor Markers in Lung Cancer. Tumormarker beim Bronchialkarzinom
Open Access
- 1 January 2001
- journal article
- research article
- Published by Walter de Gruyter GmbH in Journal of Laboratory Medicine
- Vol. 25 (9-10) , 353-361
- https://doi.org/10.1515/labm.2001.25.9-10.353
Abstract
No abstract availableThis publication has 22 references indexed in Scilit:
- Immunoradiometric Assay of Chromogranin a in the Diagnosis of Small Cell Lung Cancer: Comparative Evaluation with Neuron-Specific EnolaseThe International Journal of Biological Markers, 2001
- Tissue Polypeptide-Specific Antigen and Carcinoembryonic Antigen for Early Prediction of Recurrence in Lung AdenocarcinomaAmerican Journal of Clinical Oncology, 2000
- Pro-gastrin-releasing peptide, neuron specific enolase and chromogranin A as serum markers of small cell lung cancerLung Cancer, 2000
- Laboratory Variables as Additional Staging Parameters in Patients with Small-Cell Lung Carcinoma. A Systematic Reviewcclm, 1999
- PROGNOSTIC MARKERS IN RESECTABLE NON–SMALL CELL LUNG CANCERHematology/Oncology Clinics of North America, 1997
- Usefulness of longitudinal evaluation of Cyfra 21-1 variations in advanced lung cancer monitoringLung Cancer, 1997
- Discriminant analysis on small cell lung cancer and non-small cell lung cancer by means of NSE and CYFRA-21.1European Respiratory Journal, 1995
- Cyfra 21-1 as a Biologic Marker of Non-small Cell Lung CancerChest, 1995
- Effect of Hemodialysis on the Concentration of the Seven Tumor Markers Carcinoembryonic Antigen, Alpha-Fetoprotein, Squamous Cell Carcinoma-Related Antigen, Neuron-Specific Enolase, CA 125, CA19–9 and CA 15–3 in Uremic PatientsAmerican Journal of Nephrology, 1991
- Serum Neuron-Specific EnolaseChest, 1985